[Basic-bolus therapy of diabetic children and adolescents using Novo Pens].
A multiple injection regimen using a pen-injector (Novo Pen) was applied to 34 diabetic adolescents (age: 15.4 +/- 2.4 years). During the observation-period of 6 months HbA1c fell significantly from 8.98 +/- 0.31 to 7.82 +/- 0.25 rel%. At the end of the study all patients wanted to continue this regimen considering the advantage of improved life quality compensating for the inconvenience of multiple injections.
Schober
E
E
Borkenstein
M
M
Frisch
H
H
D000293:Adolescent; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007273:Injections, Intramuscular; D007328:Insulin / Q000008:administration & dosage*; D049528:Insulin, Long-Acting; D061389:Insulin, Regular, Pork; D008297:Male
D006442:Glycated Hemoglobin; D007328:Insulin; D049528:Insulin, Long-Acting; D061389:Insulin, Regular, Pork; C023501:Insulin, Ultratard; C000006:insulin, neutral
Basis-Bolus-Therapie bei diabetischen Kindern und Jugendlichen unter Verwendung des Novo Pens.